The E3-ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of Fu by Schweiger, S. et al.
 
Repository of the Max Delbrück Center for Molecular Medicine (MDC) 
in the Helmholtz Association  
 
http://edoc.mdc-berlin.de/14376  
 
 
 
 
 
The E3-ubiquitin ligase MID1 catalyzes ubiquitination and cleavage of 
Fu 
 
Schweiger, S. and Dorn, S. and Fuchs, M. and Koehler, A. and Matthes, F. and Mueller, E.C. and 
Wanker, E. and Schneider, R. and Krauss, S. 
 
 
 
 
 
This is a copy of the original article. 
 
This research was originally published in Journal of Biological Chemistry. Schweiger, S. and Dorn, 
S. and Fuchs, M. and Koehler, A. and Matthes, F. and Mueller, E.C. and Wanker, E. and 
Schneider, R. and Krauss, S. The E3-ubiquitin ligase MID1 catalyzes ubiquitination and cleavage 
of Fu. J Biol Chem. 2014; 289: 31805-31817. © 2014 by The American Society for Biochemistry 
and Molecular Biology, Inc. 
 
 
 
Journal of Biological Chemistry 
2014 NOV 14 ; 289(46): 31805-31817 
Doi: 10.1074/jbc.M113.541219   
  
American Society for Biochemistry and Molecular Biology 
Schneider and Sybille Krauß
Eva-Christina Müller, Erich Wanker, Rainer
Fuchs, Andrea Köhler, Frank Matthes, 
Susann Schweiger, Stephanie Dorn, Melanie
  
Ubiquitination and Cleavage of Fu
The E3 Ubiquitin Ligase MID1 Catalyzes
Cell Biology:
doi: 10.1074/jbc.M113.541219 originally published online October 2, 2014
2014, 289:31805-31817.J. Biol. Chem. 
  
 10.1074/jbc.M113.541219Access the most updated version of this article at doi: 
  
.JBC Affinity SitesFind articles, minireviews, Reflections and Classics on similar topics on the 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/289/46/31805.full.html#ref-list-1
This article cites 40 references, 10 of which can be accessed free at
 at M
A
X
 D
ELBRU
ECK
 CEN
TRU
M
 FU
E on N
ovem
ber 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 at M
A
X
 D
ELBRU
ECK
 CEN
TRU
M
 FU
E on N
ovem
ber 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
The E3 Ubiquitin Ligase MID1 Catalyzes Ubiquitination and
Cleavage of Fu
Received for publication,December 6, 2013, and in revised form, October 1, 2014 Published, JBC Papers in Press,October 2, 2014, DOI 10.1074/jbc.M113.541219
Susann Schweiger‡, Stephanie Dorn§, Melanie Fuchs¶, Andrea Köhler, Frank Matthes§, Eva-Christina Müller**,
Erich Wanker**, Rainer Schneider, and Sybille Krauß§1
From the ‡Institute for Human Genetics, Medical School, University of Mainz, 55122Mainz, Germany, the §German Center for
Neurodegenerative Diseases, 53127 Bonn, Germany, the ¶Department of Dermatology, Charité University Hospital, 10117 Berlin,
Germany, the Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, 6020 Innsbruck, Austria, and **Max
Delbrück Center for Molecular Medicine, 13125 Berlin-Buch, Germany
Background: SHH signaling is an important growth-stimulating factor in diverse cancers.
Results:MID1 catalyzes ubiquitination and proteasomal cleavage of Fu.
Conclusion: The MID1-PP2A complex regulates the activity of the SHH effector GLI3 in cancer cell lines by regulating
proteasomal cleavage of Fu.
Significance: Understanding the molecular mechanisms underlying tumorigenesis is crucial for developing therapeutic
approaches to treat cancers.
SHH (SonicHedgehog)-GLI signaling plays an important role
during embryogenesis and in tumorigenesis. The survival and
growth of several types of cancer depend on autonomously acti-
vated SHH-GLI signaling. A protein complex containing the
ubiquitin ligaseMID1 andprotein phosphatase 2A regulates the
nuclear localization and transcriptional activity of GLI3, a tran-
scriptional effector molecule of SHH, in cancer cell lines with
autonomously activated SHH signaling. However, the exact
molecular mechanisms that mediate the interaction between
MID1 and GLI3 remained unknown. Here, we show that MID1
catalyzes the ubiquitination and proteasomal cleavage of the
GLI3 regulator Fu. Our data suggest that Fu ubiquitination and
cleavage is one of the key elements connecting the MID1-PP2A
protein complex with GLI3 activity control.
Members of the Hh (Hedgehog) protein family are keymedi-
ators of several fundamental processes during embryonic
development including growth, body patterning, and tissue
morphogenesis (reviewed inRefs. 1 and 2). In response to extra-
cellular stimulation, Hh proteins bind to their receptor Patched
(Ptch), a 12-span transmembrane protein. In the absence of Hh
ligands, Ptch inhibits Smoothened (Smo), a second transmem-
brane protein. Hh binding leads to the relief of Smo and the
activation of a downstream signaling cascade (3). InDrosophila,
the cytosolic transduction of the Hh signal involves a microtu-
bule-associated protein complex containing Fu (Fused), the
GLI family transcription factor Ci (Cubitus Interruptus), the
kinesin-like protein Cos2 (Costal2), and SuFu (Suppressor of
Fused) (reviewed in Ref. 4). UponHh stimulation, the Fu kinase
gets phosphorylated and thereby activated, enabling it to phos-
phorylate Cos2 at two different positions (5, 6). Phosphoryla-
tion of Cos2 leads to the release of the entire protein complex
from themicrotubules. Cimaturates into a transcriptional acti-
vator and translocates into the nucleus, where it stimulates
transcription of Hh target genes.
Although Hh signaling seems more complex in mammals,
several elements of the Hh pathway are highly conserved
throughout species. Three homologues of Hh (SHH (Sonic
Hedgehog), DHH (Desert Hedgehog), and IHH (Indian Hedge-
hog) (7)), two Ptch homologues (PTCH1 (Patched 1) and
PTCH2 (Patched 2) (8)), and three Ci homologues (GLI1, GLI2,
andGLI3) (9, 10) have been identified inmammalian cells (3, 4).
Also, a human orthologue of the Fu kinase (11) has been dis-
covered. However, transduction of Hh signals and in particular
the function of the mammalian Fu kinase seem to differ sub-
stantially from Drosophila and are discussed controversially in
the literature. Some studies have suggested that human Fu
enhances the activator function of GLI proteins similar to its
role in Drosophila (11–13). Fu knock-out mice, however, do
not display typical SHH deficiency phenotypes. Instead, they
develop normally until birth, but fail to thrive within the first
week, and develop severe growth retardation and hydrocepha-
lus. They die within the first 3 weeks after birth (14, 15).
These data show that although Fu is dispensable for Hh sig-
naling during embryogenesis, its fundamental function evolves
after birth, suggesting two different mechanisms of Hh signal
transduction in mammals: one is Fu-dependent and important
for the regulation of growth andbrain formation after birth, and
a second one is Fu-independent and either solely responsible
for embryonic Hh signaling or at least able to back up for the
Fu-dependent pathway in embryonic tissues.
Likewise, mechanisms leading to the activation of mamma-
lian GLI proteins are much less well understood than in Dro-
sophila. As we have shown previously, a protein complex con-
sisting of the microtubule-associated ubiquitin ligase MID1,
the 4 protein, and protein phosphatase 2A (PP2A)2 regulates
the nuclear localization and transcriptional activity of one of1 To whom correspondence should be addressed: German Center for Neuro-
degenerative Diseases, University of Bonn/BMZ1, Sigmund-Freud-Str. 25,
53127 Bonn, Germany. Tel.: 49-228-28751113; E-mail: sybille.krauss@
dzne.de. 2 The abbreviation used is: PP2A, protein phosphatase 2A.
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the three transcriptional effector molecules of mammalian
SHH signaling, GLI3, in cancer cell lines with autonomously
activated SHHsignaling (16, 17). Via its ubiquitin ligase activity,
the RING finger protein MID1 targets PP2A toward ubiquitin-
dependent degradation by the proteasome and thereby
decreases PP2A activity at the microtubules (18). Furthermore,
we found that MID1 activity is fundamental for the maturation
of GLI3 into a transcriptional activator. However, the exact
molecular mechanisms that mediate the interaction between
MID1 and GLI3 remain unknown.
Here we show that in mammalian cells, the kinase domain of
Fu is cleaved off upon ubiquitination of Fu leading to the
expression of a 90-kDa fragment. We further show that this
ubiquitination is mediated through interaction of Fu with the
MID1 ubiquitin ligase, which targets Fu toward Lys6, Lys48, and
Lys63 ubiquitination. Blockage of the proteasome leads to a sig-
nificant increase in abundance of full-length Fu compared with
the 90-kDa fragment. Likewise, knockdown of MID1 leads to a
remarkable reduction of the 90-kDa fragment. Together with
the observation that knockdown of Fu, as well as inhibition of
the proteasome, significantly decreases nuclear GLI3, whereas
overexpression ofkinase Fu increases nuclear localization and
activity of GLI3, these data suggest that Fu and its ubiquitina-
tion and cleavage are key elements connecting the MID1 pro-
tein complex with GLI3 activity control.
EXPERIMENTAL PROCEDURES
Immunofluorescence—For immunofluorescence experiments,
HeLa or U373MG cells were plated on coverslips (in 6-well
plates) at a density of 1  105 cells/well 1 day before transfec-
tion. Cells were transfected with the respective plasmids using
Polyfecttransfectionreagent(Qiagen)accordingtothemanufac-
turer’s instructions. Twenty-four hours after transfection, cells
were fixed with 3.7% paraformaldehyde in PEM buffer (10
PEM contains 1 M Pipes, 0.05 M EGTA, 0.02 M MgCl2, pH 7.0).
The GFP-GLI3 signal distribution in individual cells occurred
in three patterns: exclusively nuclear fluorescence, evenly
stained throughout the cytosol and nucleus, or predominantly
cytosolic fluorescence. 100 transfected cells per coverslip were
counted and classified in one of the three groups. Each experi-
ment was repeated in triplicate. The data shown represent
means S.D. scored per group from three independent exper-
iments of 100 cells each. Statistical significance was evaluated
using TTest (two-tailed, homoscedastic) or one-way analysis of
variance with post hocDunnett’s test to accommodate formul-
tiple comparisons.
Transfection and Western Blotting—1 105 HeLa cells/well
of a 6-well plate were seeded 24 h prior transfection. Transfec-
tions with the respective plasmids were performed using
Polyfect transfection reagent (Qiagen) according to the manu-
facturer’s instructions. For analysis of total cell lysates 48 h after
transfection, cells were lysed in 2 Magic Mix (48% urea, 15
mMTris-HCl, 8.7% glycerol, 1% SDS, 0.004% bromphenol blue,
143mM-mercaptoethanol). Samples were denatured at 95 °C,
separated on SDS gels, and blotted on PVDF membranes
(Roche).
Knockdown Experiments—Twenty-four hours before trans-
fection, HeLa cells were seeded into 6-well plates at a density of
1  105 cells/well. Cells were transfected with 1.3 g of syn-
thetic siRNA per well using Oligofectamine (Invitrogen)
according to the manufacturer’s instructions. Sequences of
siRNAs are listed in Table 1.
Real Time PCR—Twenty-four hours before treatment, HeLa
cells were seeded at a density of 1  105 cells/well of a 6-well
plate. Cells were transfected with siRNAs as described. Total
RNA was isolated using an RNeasy mini kit (Qiagen) following
the manufacturer’s instructions. cDNA was synthesized using
the TaqMan reverse transcription reagents kit (Applied Biosys-
tems), and real time PCR was carried out using the SYBRGreen
PCR master mix (Applied Biosystems) according to the man-
ufacturer’s instructions with an ABI 7900HT cycler under the
following conditions: 50 °C for 2 min, 95 °C for 10 min, [95 °C
for 15 s, and 60 °C for 1 min] for 40 cycles and then a dissocia-
tion stage of 95 °C for 15min, 60 °C for 15min, and 95 °C for 15
min. Sequences of primers are listed (Table 2).
Luciferase Reporter Assay—4  104 HeLa cells/well of a
12-well plate were seeded 24 h prior transfection. Reporter
plasmids containing eight GLI binding sites linked to firefly
luciferase (1.5 g of DNA/well) were co-transfected with GFP-
GLI3 constructs (1g ofDNA/well) andRenilla luciferase (1 ng
ofDNA/well) for normalization. Transfectionswith the respec-
tive plasmidswere performed using JetPEI (Polyplus Transfec-
tions) according to the manufacturer’s instructions. The
reporter assays were carried out using the Dual-Luciferase
Reporter 1000 assay system (Promega) following the manu-
facturer’s instructions. Luciferase intensities were measured in
a Centro Luminometer LB 960 (Berthold).
Immunoprecipitation—For immunoprecipitation experi-
ments, HeLa cells were plated in 75-cm2 flasks at a density of
8 105 1 day prior to transfection. Cells were transfected with
the respective plasmids using JetPEI transfection reagent
(Polyplus Transfections) according to the manufacturer’s
instructions. 48 h after transfection, the cells were lysed by son-
ication in IP buffer (containing 50 mM Tris, pH 7.5, 2.5 mM
MgCl2, 100 mM NaCl, 1 mM DTT, PhosStop (phosphatase
TABLE 1
siRNA sequences
siRNA Gene targeted Target sequence (5-3)
Fu si2 Fu AAGGCACACCACTCTATATGTCT
Fu si3 Fu AAGGTAAAAGTAGTAGATTGGGA
Fu si1 Fu AAGAGTCTACTGAAGTGACACT
MID1si-2 MID1 TGCCATTGGTCTTGCTTACAA
MID1si-4 MID1 GGATTACAACTTTTAGGAATT
TABLE 2
Primer sequences
Primer name
(real time PCR)
Target
gene Sequence (5-3)
GAPDH-f1 GAPDH CCACCCATGGCAAATTCC
GAPDH-r1 GAPDH TGGGATTTCCATTGATGACAAG
GAPDH-f2 GAPDH CCACATCGCTCAGACACCAT
GAPDH-r2 GAPDH AAATCCGTTGACTCCGACCTT
CCND1-f1 CCND1 TGGGTCTGTGCATTTCTGGTT
CCND1-r1 CCND1 GCTGGAAACATGCCGGTTAC
CCND1-f2 CCND1 TGCGCTGCTACCGTTGACT
CCND1-r2 CCND1 AGCGATTGTAATATTTCCAAACC
Fu-f1 Fu TGTACAAGGGTCGAAGAAAATACAGT
Fu-r1 Fu GAGCGCCCCAATTTTGG
Fu-f2 Fu CGCATCCTACACCGAGATATGA
Fu-r2 Fu CAAATCCAAAGTCACAGAGCTTGA
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inhibitor mixture; Roche), complete (protease inhibitor mix-
ture; Roche)). Immunoprecipitation was carried out using
either protein G-Agarose (Roche) combined with anti-V5
(Invitrogen) or anti-HA (Covance) antibodies or anti-FLAG
M2 agarose (Sigma) following the manufacturer’s instructions.
Mass Spectrometry—SDS gels of immunoprecipitates were
stainedwith Imperial Protein Stain (Pierce). The bands of inter-
est were excised, trypsinized, and analyzed by chromatographic
separation on a LC Packings 75-m PepMap C18 column
(Dionex, Idstein, Germany) using a capillary liquid chromatog-
raphy CapLC system delivering a gradient to formic acid (0.1%)
and acetonitrile (80%). Eluted peptides were ionized by electro-
spray ionization on a Q-TOF hybrid mass spectrometer
(Micromass, Manchester, UK). The mass spectral data were
processed into peak lists containing m/z value, charge state of
the parent ion, fragment ion masses, and intensities and corre-
lated with the SwissProt database using Mascot software (19).
Constructs—Either the full-length Fu cDNA (coding for
amino acids 1–1315), Fu cDNA coding for amino acids 441–
1315, or Fu cDNA coding for amino acids 1–447 was PCR-
amplified on the clone IRAKp961P0834 (RZPD) and cloned
either into the V5 tagmultiple cloning side of pBUDCE4 (Invit-
rogen) using the restriction enzymes NotI and BglII or into the
multiple cloning site of pTL1-HA2 (a derivative of the pSG5-
vector (Stratagene), in which a SV40 early promoter and amul-
tiple cloning site with an upstream HA epitope has been
inserted, kindly provided by E. Wanker) using the restriction
enzymes EcoRV and BglII. For expression in Escherichia coli,
either the full-length Fu cDNA, or the Fu cDNA coding for
amino acids 351–450 were PCR-amplified and cloned into the
multiple cloning site of the pET-32a() vector (Novagen) using
the restriction enzymes (EcoRV and HindIII for full-length Fu
or SalI and NotI for amino acids 351–450). The full-length
MID1-cDNA was PCR-amplified and cloned into the multiple
cloning site of the vector pCMVTag2A (Stratagene) using the
restriction enzymes HindIII and EcoRI. A MID1 deletion
construct lacking the sequence coding for amino acids 1–196
was synthesized by usage of the QuikChange site-directed
mutagenesis kit (Stratagene) following the manufacturer’s
instructions. The full-length ubiquitin-cDNA was PCR-ampli-
fied and cloned into the p3xFLAG-CMV10-vector (Sigma)
using the restriction enzymes HindIII and BamHI. The amino
acid changes K48R, K63R, and KO (all lysines mutated to argi-
nine) were inserted into this construct by mutagenesis. HA-
tagged wild type or mutant ubiquitin was cloned into the
pcDNA-vector (these constructs were kindly provided by A.
Trockenbacher).
Fu Expression in E. coli and Purification—N-terminal His-
tagged Fu was expressed in E. coli BL21-CodonPlus(DE3)-RIL
under standard conditions. Cell pellets were resuspended in
binding buffer (50 mM sodium phosphate, pH 8.0, 300 mM
NaCl, 20 mM imidazole) and lysed with a French press. The
extract was centrifuged at 12,000 rpm for 30 min at 4 °C. Puri-
fication of His-Fu was carried out using nickel-nitrilotriacetic
acid-agarose (Qiagen). After binding of the protein to the nick-
el-nitrilotriacetic acid-agarose, the column was washed with
wash buffer (50 mM sodium phosphate, pH 6.0, 300 mM NaCl,
20 mM imidazole, 10% glycerol, 0.25% Tween 20) and finally
eluted with imidazole. All buffers contained 20 mM imidazole
for enhanced stringency, the elution buffers contained 250–
500 mM imidazole and 10% glycerol for more stable solubility.
All fractions were analyzed on a SDS-PAGE and finally pooled.
Fu Antibody—A Fu peptide spanning amino acids 351–450
was expressed in E. coli and purified as described. After dialysis
of the purified peptide against PBS, the peptide was used for
immunization of a rabbit (Biogenes). The Fu-specific antibod-
ies were affinity-purified from the rabbit serum using a Sul-
foLink coupling gel (Pierce) column thatwas coatedwith the Fu
peptide.
In Vitro Ubiquitination—HEKT cells were plated in 150-cm2
flasks at a density of 2 106 1 day prior transfection. Cells were
transfected with the respective plasmids using JetPEI transfec-
tion reagent (Polyplus Transfections) according to the manu-
facturer’s instructions. 48 h after transfection cells were lysed
by sonication in IP buffer (containing 50 mM Tris, 100 mM
NaCl, 5 mM MgCl2, 1 mM DTT, Complete (protease inhibitor
mix; Roche), 0.5% Nonidet P-40). Immunoprecipitation was
carried out using protein G-Agarose (Roche) and anti-HA anti-
bodies (Covance) for HA-Fu or anti-FLAGM2 agarose (Sigma)
for MID1-FLAG following the manufacturer’s instructions.
Peptide elution of FLAG-MID1 was done using FLAG peptides
(Sigma) following the manufacturer’s instructions. For in vitro
ubiquitination, we used the ubiquitinylation kit (Biomol) fol-
lowing the manufacturer’s instructions.
RESULTS
Fu Regulates the Subcellular Localization and Transcrip-
tional Activity of GLI3—As we have reported previously, the
MID1-4-PP2A complex regulates the subcellular localization
and transcriptional activity of GLI3 in cancer cell lines (16, 17).
However, our data also suggested that this regulation indirectly
involves otherGLI3-interacting proteins. Because the Fu kinase
promotes the nuclear localization of GLI proteins (11) and is
up-regulated in cancer cells (20), we tested for a putative
involvement of Fu in the regulation of GLI3 subcellular local-
ization and activity. HeLa and U373MG cells were co-trans-
fected with GFP-tagged GLI3 (GFP-GLI3) and either nonsi-
lencing or three different Fu specific siRNA oligonucleotides
and analyzed for GLI3 subcellular localization by light micros-
copy as described previously (16, 17). The transcriptional activ-
ity of GLI3 was monitored by real time PCR of the GLI3 target
cyclin D1 and in a reporter assay using a construct in which
eight GLI-binding sites are fused to a luciferase gene. As shown
in Fig. 1, Fu knockdown led to significant reduction of the
nuclear localization of GFP-GLI3 (concomitantly, fractions of
cells with cytosolic GLI3 were increased) (Fig. 1A) and GLI3
transcriptional activity as measured by expression of the GLI3-
target cyclin D1 by real time PCR (Fig. 1B) and in a luciferase
reporter assay (Fig. 1C). The efficiency of the knockdown pro-
cedure was monitored by real time PCR amplifying the endog-
enous FumRNA and byWestern blot (Fig. 1B). In our previous
studies, we have shown that the MID1 complex, similar to Fu,
regulates the subcellular localization and activity of GLI3 (16,
17). Because our data also suggested that this regulation is indi-
rect and involves anotherGLI3-interacting protein, we hypoth-
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FIGURE 1. Subcellular localization and transcriptional activity of GLI3 after Fu knockdown. A, subcellular distribution of GFP-GLI3 in HeLa (top panel) or
U373MG (middle panel) cells after co-transfection with either nonsilencing control siRNAs or three different Fu-specific siRNAs. GFP signal distribution in
individual cells occurred in three patterns: exclusively nuclear fluorescence, even staining throughout cytosol and nucleus, or predominantly cytosolic
fluorescence. Transfected cells were randomly chosen, counted, and classified in one of the three groups. The data shown represent percentages of cells
showing strictly nuclearGFP-GLI3 localization (meansS.D. scoredpergroup fromthree independent experimentsof 100cells each). *,p0.05.Bottompanel,
representativepicturesof cells showingGFPGLI3 localizationafter transfectionwithnonsilencingcontrol siRNAsor threedifferent Fu-specific siRNAs.B, relative
Cyclin D1 (upper panel) or Fu (lower panel)mRNAamounts inHeLa cells transfectedwith either nonsilencing control siRNAs or three different Fu-specific siRNAs
as measured by real time PCR (lower panel, left) and Western blot (lower panel, right) using Fu- or tubulin-specific antibodies. Left, columns represent mean
values of four samplesmeasured in parallel S.D. GAPDHwas used for normalization. *, p 0.05. C, GLI3 reporter assay. Firefly luciferase under the control of
eight GLI-binding sites was co-transfected with three different Fu-specific siRNAs or control-siRNAs. As an internal transfection control, Renilla luciferase was
included and used for normalization. The columns show relative firefly luciferase signals from four samples S.D. *, p 0.05.
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esized that Fu and MID1 could interact, regulating GLI3 sub-
cellular translocation and maturation.
Fu Interacts with the Ubiquitin Ligase MID1—To assess a
putative physical interaction between Fu and theMID1 protein
complex co-immunoprecipitation experiments with HeLa cell
lysates overexpressing Fu-V5 and FLAG-MID1 using V5 anti-
bodies, FLAG antibodies, and unspecific immunoglobulins as
negative control were performed. Subsequently, immunopre-
cipitates were analyzed on Western blots. A clear co-purifica-
tion of Fu-V5 and FLAG-MID1 was detected, indicating that
both proteins are part of the same protein complex (Fig. 2A).
Interestingly, in the FLAG immunoprecipitate, not only full-
length Fu-V5 was co-purified, but also a high molecular weight
ladder was detected, indicating post-translational modification
of Fu-V5 when interacting with MID1.
Because MID1 is a ubiquitin ligase, ubiquitination was one
possibility of how Fu could be post-translationally modified
when complexing with MID1. This hypothesis is supported by
observations of Kise and colleagues (21), who have described
that Fu is ubiquitinated in mammalian cell lines. To investigate
whether MID1 acts as an E3 ubiquitin ligase catalyzing the
ubiquitination of Fu, in vitro ubiquitination assays were per-
formed. In these assays, immunopurified FLAG-MID1 (as
putative E3 enzyme) and immunopurifiedHA-Fu (as substrate)
were incubated together with an E1 enzyme and a panel of E2
enzymes in a buffer containing biotinylated ubiquitin. Ubiquiti-
nation of Fu was visualized on Western blots using HRP-
streptavidin. As negative controls, HA-Fu and E1 and E2
enzymes were incubated with FLAG immunoprecipitate
obtained from HeLa cells without MID1-FLAG expression.
Ubiquitination of HA-Fu could be detected with the E2
enzymesUbcH5a,UbcH5b, andUbcH5c (Fig. 2B). Importantly,
this ubiquitination was significantly enhanced in the presence
of immunopurified MID1. These data suggest that MID1
indeed has E3 ubiquitin ligase activity on Fu.
Fu Polyubiquitination Involves Lys6, Lys48, and Lys63 Linkage
and Is Mediated by the MID1 Ubiquitin Ligase—Fu had previ-
ously been shown to be ubiquitinated and degraded via the
proteasome (21). In confirmation of these data, we performed
co-immunoprecipitation of HA-tagged Fu and FLAG-tagged
ubiquitin from cells that were incubated in the presence of the
proteasome inhibitor MG-132. The enrichment of polyubiq-
uitinated Fu that was detected after incubationwith the protea-
some inhibitor MG-132 (Fig. 3A) indicates a role of the protea-
some in the metabolism of ubiquitinated Fu.
Polyubiquitin chains are covalently linked via isopeptide bonds
usingoneof seven lysines in theubiquitinprotein.Thebest studied
polyubiquitin chains, linked via Lys48, target proteins for degrada-
tionby theproteasome.However, chains can alsobe linked via any
other of the six lysines in ubiquitin (e.g.Lys63), aswell as theN-ter-
minal amino group of methionine. Lys63-linked ubiquitin chains
seem to have distinct functions, are also involved in proteasomal
processes, or play a role in nonproteolytic processes like DNA
repair or protein trafficking.
To analyze the nature of the ubiquitin chain in vitro ubiquiti-
nation assays using WT ubiquitin, ubiquitin containing only
Lys48, ubiquitin containing only Lys63, or ubiquitin in which all
Lys residues had been mutated to arginine (KO) were per-
formed. Ubiquitination of HA-tagged Fu could be detected
with WT, Lys63, and Lys48 (Fig. 3B) and was significantly
increased after addition of immunopurified MID1 (2.8  0.5-
fold increase for WT, 3.5  0.5-fold increase for Lys63, and
3.4 0.6-fold increase for Lys48). In this kind of assay, a band
of monoubiquitinated Fu would be expected to appear in the
KO sample if the polyubiquitin chain is added onto Fu in a
stepwise manner. After long exposure times of the same
blots, a very faint band was seen in the KO lane (data not
shown). The reason for this very weak appearance might be
either a fast turnover of monoubiquitinated into polyubiq-
uitinated Fu. Alternatively, Fu could get ubiquitinated by
FIGURE 2. Interaction of Fu with the ubiquitin ligase MID1. A, co-immunoprecipitation of FLAG-MID1 and Fu-V5. Immunoprecipitations from HeLa cell
lysates overexpressing FLAG-MID1 and Fu-V5 were performed using anti-V5 antibodies, anti-FLAG-M2-agarose, or nonspecific IgGs as negative control.
Immunoprecipitates were analyzed by Western blot. FLAG-MID1 (lower panel) and Fu-V5 (upper panel) were detected using the respective antibodies. The
full-length FLAG-MID1 and Fu-V5 bands, as well as shorter Fu-V5 fragments and a highmolecular weight Fu-V5 smear are depicted. B, in vitro ubiquitination of
HA-Fu. HA-Fu was incubated with an E1 enzyme, with a panel of 11 different E2 enzymes (UbcH1, UbcH2, UbcH3, UbcH5a, UbcH5b, UbcH5c, UbcH6, UbcH7,
UbcH8, UbcH10, and Ubc13), and with (right panels) or without (left panels) the E3 enzymeMID1 and analyzed on a Western blot. The binding of biotinylated
ubiquitin to HA-Fu was visualized using HRP-streptavidin (upper panels). To show equal loading of HA-Fu to each reaction, the same membranes were
incubated with anti-HA antibodies (lower panels). The full-length HA-Fu bands, as well as shorter HA-Fu fragments (asterisk), are depicted.
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preassembled polyubiquitin chains. Some E2 enzymes are
capable of preforming polyubiquitin chains on their active
site cysteine, which are then transferred en bloc onto the
substrate (22, 23). Taken together, these data clearly show
that MID1 is able to catalyze both Lys48- and Lys63-linked
ubiquitination of Fu in vitro.
MID1 Catalyzes Ubiquitination and Cleavage of Fu
31810 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 46•NOVEMBER 14, 2014
 at M
A
X
 D
ELBRU
ECK
 CEN
TRU
M
 FU
E on N
ovem
ber 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
To figure out whether one mixed polyubiquitin chain or two
independent polyubiquitin chains (one linked via Lys48 and
another one linked via Lys63) exist on the Fu protein, we immu-
nopurified Fu-V5 and analyzed it by mass spectrometry. We
identified only one lysine residue (Lys24) to be modified by
ubiquitin. However, because sequence coverage in this experi-
mentwas only50%, this did not rule out the existence of other
ubiquitinated residues. Therefore, we performed an in vitro
ubiquitination assay using methylated ubiquitin. Methylated
ubiquitin cannot be linked into polyubiquitin chains, and there-
fore incorporates as a single ubiquitin-moiety, allowing the sep-
aration of molecules that are ubiquitinated on several sites by
theirmolecular weight. In vitro ubiquitination of Fuwithmeth-
ylated ubiquitin revealed a single band at a slightly increased
molecular weight, suggesting the presence of only one ubiquiti-
nation site (Fig. 3C). To further strengthen the hypothesis that
Fu gets ubiquitinated at a single lysine residue, Lys24, we used a
Fu deletion construct that lacks amino acids 8–100 (8–100).
We performed co-immunoprecipitation of V5-tagged Fu (full-
length and 8–100) and FLAG-tagged ubiquitin. Full-length
Fu was detected in the FLAG immunoprecipitate, whereas
8–100 was not detectable, suggesting that this construct is
ubiquitinated (Fig. 3D). Together, these data suggest the pres-
ence of a single polyubiquitination chain linked to Lys24 of Fu
including both Lys48- and Lys63-linked ubiquitin molecules.
However, these results do not preclude that this ubiquitin chain
also contains ubiquitin molecules that are linked via one of the
other five lysines of ubiquitin. To assess this, we have per-
formed an in vitro ubiquitination assay using ubiquitinmutants
in which all but one of the lysine residues have beenmutated. In
this experimentMID1 also catalyzed linkagewith amutant that
only contained Lys6 (Fig. 3E). To verify this, we performed co-
immunoprecipitation of V5-tagged Fu and FLAG-tagged WT
ubiquitin, as well as ubiquitin that contained only Lys6. Full-
length Fuwas detected in the FLAG immunoprecipitate of both
WT and Lys6 ubiquitin (Fig. 3F). Taken together, our data sug-
gest the presence of a single polyubiquitination chain linked to
Lys24 of Fu including Lys6-, Lys48-, and Lys63-linked ubiquitin
molecules.
RING finger domains are a characteristic signature of many
E3 ubiquitin ligases (24). To analyze whether the catalyzing
effect of MID1 on the ubiquitination of Fu is mediated by the
RING finger domain of MID1, a MID1 deletion construct lack-
ing amino acids 1–196 was used in a similar in vitro ubiquitina-
tion assay as described above. In confirmation of a direct effect
of theMID1-RING finger on its ubiquitin ligase activity, a clear
reduction of Fu ubiquitination was detected, when immunopu-
rified RING MID1 instead of WT MID1 was added to the
assay (Fig. 3G). Similar loading of wild type and RING MID1
was controlled on Western blots (data not shown).
The previous experiments indicate that the MID1 protein is
responsible for the transfer of ubiquitin onto Fu. This could be
confirmed in a knockdown experiment performed inHeLa cells
after co-expressing Fu-V5 and HA-ubiquitin and either nonsi-
lencing or two differentMID1 specific siRNA oligonucleotides.
Fu-V5 immunoprecipitates were analyzed on a Western blot
for conjugated HA-ubiquitin. Clearly, whereas in the nonsi-
lencing control sample polyubiquitination of Fu-V5 was quite
pronounced, it was significantly reduced in the MID1 knock-
down samples. The efficiency of the knockdown procedure was
checked on a Western blot using MID1 antibodies (Fig. 3H).
Fu Is a Target of Proteasome-dependent Site-specific Cleav-
age—Notably, both in the in vitro ubiquitination assays and
when immunoprecipitating Fu-V5 (Fig. 2A, third lane), apart
from full-length Fu-band and high molecular polyubiquitin-
smear, smaller protein bands were detected. These bands could
potentially refer to cleavage products of Fu. To analyze whether
Fu is target of cleavage in the cell, Fu-V5 was immunopurified
and put on a Coomassie-stained SDS gel. Detectable bands,
several of which were congruent with the bands picked up by
the anti-V5 antibody, were analyzed bymass spectrometry (Fig.
4A and Table 3). Fu isoforms were detected in three of the
analyzed samples. Furthermore, in the 145-kDa Fu-V5 band,
ubiquitin was detected, confirming ubiquitin-specific modifi-
cation of Fu. A protein entity detected at80 kDa turned out to
be a previously described interaction partner of Fu, HSP90 (21)
(Fig. 4A, band marked with asterisk), which further confirms
the specificity of the reaction.
FIGURE 3. A, immunoprecipitation of HA-Fu conjugated to FLAG ubiquitin. HA-Fu was co-expressed with FLAG ubiquitin with or without treatment with the
proteasome inhibitor MG-132 and purified by immunoprecipitation using HA antibodies. The incorporation of ubiquitin was then detected onWestern blots
using FLAG antibodies (upper panel). To show the loading of HA-Fu to each lane, the samemembranes were incubated with anti-Fu antibodies (lower panel).
B, in vitroubiquitination of HA-Fu. HA-Fuwas incubatedwith an E1 enzyme,with the E2 enzymeUbcH5b, andwith (MID1) orwithout (MID1) the E3 enzyme
MID1andanalyzedonaWesternblot. In this reaction, eitherWTubiquitinor ubiquitinproteins inwhich all lysineshavebeenmutated to arginine (KO), inwhich
all lysines but Lys48 have beenmutated to arginine (Lys48), or in which all lysines but Lys63 have beenmutated to arginine (Lys63) were applied. The binding of
biotinylated ubiquitin to HA-Fu was visualized using HRP-streptavidin (upper panel). To show equal loading of HA-Fu to each reaction, the same membranes
were incubatedwithanti-HAantibodies (lower panel).C, in vitroubiquitinationofHA-Fu.HA-Fuwas incubatedeitherwithoutorwith amixtureof anE1enzyme,
theE2enzymeUbcH5b, the E3enzymeMID1, andmethylatedubiquitin andanalyzedonaWesternblot. Thebindingofmethylatedubiquitin toHA-Fu induced
a shift in the molecular weight, which was detected with HA antibodies. D, immunoprecipitation of Fu-V5 conjugated to FLAG ubiquitin. Full-length Fu-V5 or
adeletion construct lackingaminoacids 8–100 (8–100)was co-expressedwithFLAGubiquitin.Ubiquitinatedproteinswerepurifiedby immunoprecipitation
usinganti-FLAGbeads.UbiquitinatedFuwas thendetectedonWesternblotsusingV5antibodies.E, in vitroubiquitinationof Fu-V5. Fu-V5was incubatedeither
without or with amixture of an E1 enzyme, the E2 enzymeUbcH5b, the E3 enzymeMID1, and different ubiquitinmutants in which either all (KO) or all but one
lysine have beenmutated. Samples were analyzed on aWestern blot onwhich ubiquitin (upper panel) or Fu-V5 (lower panel) was detected. F, immunoprecipi-
tation of Fu-V5 conjugated to FLAG ubiquitin. Full-length Fu-V5 was co-expressed with either WT FLAG ubiquitin or FLAG ubiquitin in which all lysines apart
from Lys6 were mutated. Ubiquitinated proteins were purified by immunoprecipitation using anti-FLAG beads. Ubiquitinated Fu was then detected on
Western blots using V5 antibodies.G, in vitroubiquitination of His-Fuwith an E1 enzyme, the E2 enzymeUbcH5b, and the E3 enzymeMID1 as described for Fig.
2B. Either full-lengthMID1 (MID1) or aMID1deletion constructmissing the first 196 amino acids (including the RING finger domain;RING) were used. To show
equal loading of His-Fu to each reaction, the same membranes were incubated with anti-Fu antibodies (lower panel). H, immunoprecipitation of Fu-V5
conjugated toHAubiquitin. Fu-V5andHAubiquitinwere co-transfectedwitheithernonsilencingcontrol siRNAsor twodifferentMID1-specific siRNAs (MID1si2
andMID1si4). Left panel, Fu-V5was purified by immunoprecipitationwith V5 antibodies (IP:V5). Pulldownswith unspecific IgGswere used as negative controls
(IP:IgG). The immunoprecipitateswere analyzedonWestern blots detecting the Fuubiquitinationwith anti-HA antibodies (upper panel). To visualize loadingof
Fu-V5 to each lane, the samemembranes were incubated with anti-V5 antibodies (lower panel). Right panel, the efficiency of the MID1 knockdown procedure
was monitored onWestern blots using MID1-specific antibodies (upper panel) or GAPDH antibodies as loading control (lower panel).
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Taken together, these data indicate that overexpressed
Fu-V5 undergoes multiple site-specific cleavage steps, which
result in at least three different isoforms of 145, 130, and 90
kDa. Because the 130- and 90-kDa Fu isoforms could only be
detected when using C-terminally V5-tagged Fu but not with
N-terminally tagged HA-Fu (Fig. 4B) and according to the
FIGURE 4. A, identification of different Fu isoforms by mass spectrometry. Right panel, immunoprecipitated Fu-V5 was separated on an SDS gel stained by
Coomassie. The bandsmarked by arrowswere identified as Fu isoforms bymass spectrometry; the bandmarked by asteriskwas identified as Hsp90. Left panel,
an aliquot of the same immunoprecipitate was analyzed on a Western blot using anti-V5 antibodies. B, detection of different Fu isoforms. Lysates of cells
expressingFu-V5 (left panel) or cells expressingHA-Fu (right panel)were analyzedonWesternblot. Thedifferent Fuprotein isoformsweredetectedwith anti-V5
(left panel) or anti-HA (right panel) antibodies, respectively. C, homodimerization of Fu. HA-Fu and V5-Fu were co-expressed in HeLa cells and immunoprecipi-
tatedwith anti-V5 antibodies or nonspecific IgGs as negative control. HA-Fu (lower panel) and Fu-V5 (upper panel) were visualized onWestern blots with V5 or
HA antibodies, respectively. D, lysates of nontransfected HeLa cells (right lane) or HeLa cells transfected with Fu-V5 (left lane) were analyzed onWestern blots
using the affinity-purified Fu antibody. E, immunoprecipitation of FLAG ubiquitin and detection of ubiquitin-coupled endogenous Fu. HeLa cells were
transfected with either WT FLAG ubiquitin or ubiquitin proteins in which all lysines have been mutated to arginine (KO) or in which either Lys48 or Lys63 have
been mutated to arginine (K48R or K63R). All ubiquitinated proteins from the lysates of those cells were isolated by immunoprecipitation using anti-FLAG-
agarose or mouse IgG-agarose as negative control. Ubiquitinated endogenous Fu was then detected on Western blots using anti-Fu antibodies. F, immuno-
precipitation of FLAGubiquitin and detection of ubiquitin-coupled endogenous Fu as in E. Prior to immunoprecipitation, cells were incubatedwith orwithout
the proteasome inhibitorMG-132.G, co-expression of HAubiquitin and FLAG-MID1wild type or FLAG-MID1 lacking amino acids 1–196 (RING). Ubiquitinated
proteins were purified by HA immunoprecipitation, and the relative ubiquitination of Fu was determined by Western blot analysis using Fu antibodies. H,
stabilization of endogenous Fu after MID1 knockdown. Lysates of cells transfected with nonsilencing control siRNAs (left lane) or MID1-specific siRNAs (right
lane) were analyzed on Western blot. Full-length endogenous Fu was detected with anti-Fu antibodies. Tubulin was detected on the same membranes as
loading control.
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approximate molecular weights of the cleavage products, we
concluded that cleavage sites are located in the N terminus of
the protein cutting either within or directly C-terminal of the
kinase domain. Interestingly, in the in vitroubiquitination assay
performedwithN-terminally tagged Fu, a ubiquitination smear
that migrates faster than the full-length, N-terminally tagged
HA-Fu monomer was detected. One possibility to explain
occurrence of these faster migrating Fu cleavage fragments
could be dimerization of HA-tagged Fu and endogenous Fu in
the HA immunoprecipitate. Formation of Fu dimers in the cell
was proven by co-immunopurification of HA- and V5-tagged
Fu (Fig. 4C).
Cleavage and Ubiquitination of Endogenous Fu—For the
analysis of endogenous Fu, a Fu-specific polyclonal antibody
directed against amino acids 351–450 was generated. Specific-
ity of the antibody was established in several different assays: (i)
Fuwas detected in lysates of either nontransfectedHeLa cells or
HeLa cells overexpressing Fu-V5. In Fu-V5-expressing HeLa
cell lysates, the Fu antibody specifically detected the previously
characterized bands corresponding to Fu-V5 in transfected
cells. Among those were bands at amolecularmass of90 kDa.
In nontransfected cells, however, although bands of 90 kDa
were picked up, full-length Fu was not detected (Fig. 4D). (ii)
Preincubation of the antibody with E. coli expressed and puri-
fied full-length Fu blocked off detection of only the 90-kDa
signal (data not shown), indicating specificity of this band. (iii)
Finally, specificity of the 90-kDa band was further confirmed in
a knockdown approach in which the signal was significantly
reduced after Fu-specific knockdown compared with the non-
silencing control sample (Fig. 1). Taken together, these data
show that the produced antibody detects a cleaved isoform of
Fu in a set of different (cancer) cell lines, which seems to be the
predominant Fu isoform in these cell lines.
The established Fu antibodywas then used to assess ubiquiti-
nation of endogenous Fu. HeLa cells were transfected with
FLAG-tagged ubiquitin (eitherWT,K63R,K48R, orKO).Ubiq-
uitinated proteins were immunoprecipitated using an anti-
FLAG antibody, and immunoprecipitates were analyzed on a
Western blot for the presence of endogenous Fu. In confirma-
tion of the results we had obtained with HA-Fu, a significant
number of ubiquitinated Fu species were detected. Expression
of K48R or K63R ubiquitin mutants instead of WT ubiquitin
still allowed Fu ubiquitination (Fig. 4E). Application of the pro-
teasome inhibitor MG132 prior to immunoprecipitation led to
an accumulation of (monoubiquitinated) full-length Fu (145
kDa) (Fig. 4F), which strongly suggests that the cleavage of Fu
into its shorter protein isoform is mediated by the proteasome.
Furthermore, MID1 dependence of Fu ubiquitination/cleav-
age was demonstrated by overexpression of wild type MID1 in
comparison to the inactive RING finger deletion construct in
HeLa cells. Immunoprecipitation of HA-tagged ubiquitin and
subsequent Western blot analysis of the immunoprecipitates
with the anti-Fu antibody led to an increase of both polyubiq-
uitinated Fu forms, as well as the expression of the cleaved
90-kDa fragment (Fig. 4G). These data suggest that the MID1
ubiquitin ligase promotes both ubiquitin-dependent modifica-
tion and cleavage of endogenous Fu. In line with this, MID1
knockdown led to stabilization of endogenous full-length Fu
(Fig. 4H).
N-terminally cleaved Fu promotes GLI3 nuclear localization
and transcriptional activity—The final question we asked was
whether the cleaved C-terminal Fu fragment is active in medi-
tating the nuclear translocation and activation of theGLI3 tran-
scription factor. To answer this question, we cloned a Fu dele-
tion construct lacking amino acids 1–440 (which includes the
Fu kinase domain) tomimic the 90-kDa FuC-terminal cleavage
product (N-term). This construct, as well as a corresponding
constructs containing only the isolated kinase domain of Fu or
the full-length Fu, was used to analyze effects on the subcellular
localization of GLI3. Interestingly, the N-term construct was
able to increase the nuclear localization of GLI3 similarly to
wild type Fu, whereas co-expression of the isolated kinase
domain did not induce such an effect (Fig. 5A). In line with this,
the transcriptional activity of GLI3 also increased significantly
after co-expression of full-length Fu, as well as the N-term Fu
construct (Fig. 5B). By contrast, inhibiting Fu cleavage by block-
ing the proteasome with N-acetyl-L-leucinyl-L-leucinal-L-nor-
leucinal (LLnL) led to the opposite effect. GLI3 nuclear trans-
location is inhibited after such treatment (Fig. 5C). This means
that forGLI3 translocation, the kinase domain Fu is dispensable
and that the cleaved product that we see in the different tumor
cells is responsible for translocatingGLI3 to the nucleus and for
activating GLI3.
Taken together, these results show that, mediated by a pro-
tein-protein interaction between Fu and the ubiquitin ligase
MID1, a mixed Lys6/Lys48/Lys63 ubiquitin chain is added onto
Fu. This ubiquitinmodificationmediates proteasomal cleavage
of themolecule, producing a C-terminal Fu fragment that lacks
theN-terminal kinase domain. TheC-terminal fragment rather
TABLE 3
Identified Fu peptides
Band 2 334VAPGTAPLPR343
344LGATPQESSLLAGILASELK363
369SGTGEVPSAPR379
1251EAALIALR1258
1259SLQQEPGIHQVLVSLGASEK1278
Band 3 125DMKPQNILLAK135
141LCDFGFAR148
229DFLQGLLTK237
277LPPELQVLK285
301ILTQAYK307
318HQNTGPALEQEDK330
334VAPGTAPLPR343
344LGATPQESSLLAGILASELK363
369SGTGEVPSAPR379
369SGTGEVPSAPR379
211NVASALGNLGPEGLGEELLQCEVPQR1236
1251EAALIALR1258
1259SLQQEPGIHQVLVSLGASEK1278
Band 4 25YSAQVVALK33
125DMKPQNILLAK135
229DFLQGLLTK237
277LPPELQVLK285
301ILTQAYK307
318HQNTGPALEQEDK330
334VAPGTAPLPR343
344LGATPQESSLLAGILASELK363
369SGTGEVPSAPR379
390AFPEERPEVLGQR402
571LLAQPDDSEQTLR583
1040LALMDPTSLNQFVNTVSASPR1060
1116SLLGHPENSVR1126
1237LLEMACGDPQPNVK1250
1251EAALIALR1258
1259SLQQEPGIHQVLVSLGASEK1278
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than the full-length molecule seems to play the active part in
mediating the nuclear translocation and maturation of GLI3
into an active transcriptional regulator. Our data provide a cel-
lular function for Fu, a regulatory mechanism underlying the
subcellular transposition of the transcriptional activator GLI3
that links the MID1 ubiquitin ligase with GLI3, Fu, and SHH
signaling.
DISCUSSION
Fu is an essential component of Hh signaling in Drosophila,
but the biochemical functions of mammalian Fu remain as yet
unclear. Here, we show that human Fu controls the subcellular
localization and transcriptional activity of GLI3 in cancer cell
lines. Furthermore, we found that the MID1 protein complex,
whichwe have previously shown to regulate GLI3 signaling (16,
17), interacts with Fu and catalyzes its ubiquitin-dependent
modification and site-specific cleavage. AN-term fragment is
produced by the proteasome upon MID1-dependent ubiquiti-
nation that is capable of regulating GLI3, suggesting a kinase
domain-independent mode of action of Fu on GLI3.
Fu Regulates GLI3 Signaling—The role of mammalian Fu in
GLI regulation has been discussed controversially. Although
some studies suggest that Fu is dispensable for the regulation of
GLIs, because it has little or no effect on GLI activities (12),
others have shown that human Fu binds to GLI1, GLI2, and
GLI3 and promotes nuclear localization of GLI1 and GLI2 (11).
Furthermore, human Fu was shown to enhance reporter activ-
ities of GLI1 and GLI2 (21). We show here that depletion of Fu
leads to cytosolic retention and decreased transcriptional activ-
ity of the transcription factor GLI3, an effector molecule of
SHH signaling. An explanation for these contradictory results
could be tissue/cell specificity of the function(s) of Fu. In this
study, we have used human cancer cell lines (HeLa and
U373MG), in which autonomously activated SHH signaling
was observed (16). In these cell lines, the subcellular localiza-
tion and activity ofGLIsmight be regulated differently fromcell
lines without autonomously activated SHH signaling.
Fu Ubiquitination—Polyubiquitination and proteasomal
degradation of Fu have been demonstrated previously (21). In
confirmation of these data, we show here polyubiquitination of
Fu, which increases after proteasomal inhibition. Although the-
oretically all seven lysines of ubiquitin can contribute to the
assembly of ubiquitin molecules and a variety of polyubiquitin
chains of diverse length and linkages can be produced (25, 26),
canonical Lys48-linked ubiquitin chains seem to be the princi-
pal signal for proteasomal degradation. By contrast, Lys63-
linked chains were long believed to primarily play a role in non-
proteolytic processes of protein function regulation in, for
example, DNA repair or protein trafficking. Only recently,
Lys63 ubiquitin chains have also been linked to proteasomal
cleavage and degradation (reviewed in Ref. 27). We have iden-
tified polyubiquitination of Fu involving both Lys48 and Lys63
linkage. The presence of mixed polyubiquitin chains has been
suggested earlier. Although experiments by Xu et al. (28) have
shown that only non-Lys63-linked chains are involved in pro-
teasomal degradation, other studies have provided evidence for
polyubiquitin chains with Lys63 linkages to also be involved in
degradation processes. Thus, mixed polyubiquitin chains with
FIGURE 5. Subcellular localization and transcriptional activity of GLI3
afterFu-overexpression.A, subcellular distributionofGFP-GLI3 inHeLa cells
after co-transfection with either empty vector (left columns), full-length Fu, a
Fu construct lacking the N-terminal kinase domain (N-term), or a construct
containing the isolated Fu kinase domain (N-term, right columns). GFP-GLI3
signal distribution was quantified as described for Fig. 1A. Means  S.D.
scored per group from three independent experiments of 100 cells each are
shown. *, p 0.05. B, GLI3 reporter assay. Firefly luciferase under the control
of eight GLI-binding sites was co-transfectedwith empty vector (left column),
full-length Fu (middle column), orN-term (right column). As an internal trans-
fection control, Renilla luciferase was included and used for normalization.
Columns showrelative firefly luciferase signals from four samplesS.D. *,p
0.05. C, subcellular distribution of GFP-GLI3 in HeLa cells that were treated
with orwithout the proteasome inhibitorN-acetyl-L-leucinyl-L-leucinal-L-nor-
leucinal (LLnL). Thedatawereanalyzedandarepresentedasdescribed for Fig.
1A. Means S.D. scored per group from three independent experiments of
100 cells each are shown. *, p 0.05.
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Lys11, Lys48, and Lys63 linkages are competent to mediate
cyclinB1 degradation (29), and Lys63 chains were reported to
accumulate after proteasomal inhibition (30, 31). The latter has
been confirmed in this study. The Fu protein not only seems to
bemodifiedwith ubiquitinmolecules linked via Lys6, Lys48, and
Lys63, but also these types of linkage appear to be connected
with proteasomal degradation and site-specific cleavage of Fu.
However, our data do not exclude the existence of linkage via
the N-terminal amino group of methionine, because we have
only tested linkage via different lysine residues in this study.
Fu Is a Target of Site-specific Cleavage by the Proteasome—
Weshowhere that the Fuprotein is cleaved into shorter protein
fragments. Cleavage events regulating the activity of proteins of
the SHHpathway have been described for SHHorGLI3 as well.
Although cleavage of full-length SHH is necessary to form the
active SHH-ligand (3), which then binds its receptor PTC1,
GLI3 cleavage into its repressor form takes place in the absence
of a SHH signal (32). We show here that ubiquitination of Fu
mediates its proteasomal cleavage, forming a fragment that
lacks the N-terminal serine/threonine kinase domain. Further-
more, we provide evidence that this N-term fragment rather
than the isolated kinase domain or the full-length protein plays
the active part in the regulation of the subcellular translocation
ofGLI3. This separates theGLI3 regulatory function of Fu from
its kinase activity, supporting previous reports that also have
suggested the existence of kinase domain-independent func-
tions of Fu by using kinase-inactive Fu mutants (33).
N-term Fu Fragment: A Key in the Up-regulation of SHH in
Cancer?—Interestingly, the cleaved Fu fragment represents the
major endogenous protein isoform in all cancer cell lines we
have analyzed in this study. This raises the question of whether
Fu cleavage is a process that is enhanced in cancer cells. Kise et
al. (21) showed Western blots of endogenous full-length Fu in
COS7, HEK293, and PC3 cells; however the antibody used in
this study (detecting amino acids 1–304) most probably would
not be suitable to detect the C-terminal fragments that we
detected with our antibody (detecting amino acids 351–450).
This leaves open the question of whether cleaved Fu isoforms
also exist in cell types other than those we have analyzed here.
In the future, it will be interesting to see whether the predom-
inant existence of theN-termFu fragment is characteristic for
cancer cells with autonomously activated SHH as has been
shown for the cell lines used in this study. Autonomous SHH
activation has been demonstrated to be an important growth-
stimulating factor in diverse cancers (34–37). Dysregulation of
Fu cleavage leading to an overproduction of the N-term Fu
FIGURE 6. Hypothetical model. MID1 catalyzes the ubiquitination of Fu, thereby promoting proteasomal cleavage of Fu. The C-terminal fragment of Fu
promotes nuclear localizationofGLI3 andactivates its target genes. LikeMID1 andFu knockdown, the inhibitionof theproteasome leads to cytosolic retention
of GLI3.
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fragment and an autonomous translocation and activation of
GLI3 would be a plausible mechanism to explain SHH overac-
tivation in cancer cells. Accordingly inhibition of Fu cleavage
could be a promising new target in cancer cells with autono-
mous SHH signaling.
MID1 Catalyzes Fu Ubiquitination—MID1 is a RING finger
protein, which has been shown to act as an E3 ubiquitin ligase,
targeting PP2A for proteasomal degradation (18), suggesting a
catalyzing effect of MID1 on Lys48-linked ubiquitin chains. In a
paper published by Han et al. (38), Lys63-linked autoubiquiti-
nation of MID1 mediated through its own RING finger has
been demonstrated. In this study, we have identified Fu as a
novel target of the ubiquitin ligase MID1. We show that MID1
not only catalyzes Fu ubiquitination of Lys48-linked but also of
Lys6- and Lys63-linked chains. Furthermore, we found that the
E2 enzymes UbcH5a, UbcH5b, and UbcH5c, together with the
E3 enzymeMID1, ubiquitinate Fu most efficiently. This obser-
vation is in line with data from Napolitano et al. (39), who
observed that MID1 interacts, among others, with UBCH5a,
UBCH5b, and UBCH5c in a yeast two-hybrid assay. Another
example of a RING finger protein that can catalyze linkages via
several lysine residues isMuRF1.MuRF1was shown to catalyze
different kinds of polyubiquitination events on its substrate tro-
ponin I: (i) Together with the E2 enzyme UbcH1, MuRF1 cata-
lyzes the linkage of both pure Lys48- or Lys63-linked chains,
which target the substrate for proteasomal degradation in vitro.
(ii) Together with the E2 enzyme UbcH5 MuRF1 catalyzes the
linkage of a mixed forked chain, which includes Lys48, Lys63,
and other linkages. However, these mixed forked chains have
little capacity to target the substrate for proteasomal degrada-
tion (40). Based on the observation that the corresponding E2
enzyme might control the type of the ubiquitin tail that is cat-
alyzed by the RING finger protein, we think thatMID1 together
with UbcH5 catalyzes a mixed forked chain on the Fu protein,
which mediates proteasome-dependent cleavage of the mole-
cule into a N-term Fu fragment. This fragment then carries
out Fu functions independently of its kinase domain. However,
because in all our in vitro ubiquitination assays, immunopuri-
fied MID1 was used, it cannot be fully excluded that the E3
ubiquitin ligase activity that promoted Fu ubiquitination was
provided by a so far uncharacterized co-factor being tightly
associated to the RING finger domain of MID1 that was not
removed during immunopurification.
In summary, we have shown here that Fu is involved in the
activation of SHH/GLI3 signaling in cancer cell lines. However,
Fu knock-out mice do not show phenotypes that correlate with
dysfunctional GLI3 signaling (14, 15). One explanation for this
discrepancy is that GLI3 signaling is differently regulated
depending on the cellular background: although Fu is dispen-
sable for GLI3 regulation during embryogenesis, it becomes an
important regulator in adult, tumorogenic tissue. In cancer tis-
sue, the cleavedGLI3-activatingN-term fragment seems to be
the most abundant isoform of Fu. Because both GLI3 activity
and the ubiquitination of Fu are regulated by the MID1-com-
plex, it is likely that the MID1-dependent regulation of GLI3 is
indirect andmediated by the interaction between Fu andMID1
(Fig. 6). In this scenario, MID1 catalyzes the ubiquitination of
Fu, thereby promoting the production of the cleaved isoform.
TheN-term isoform is necessary to promote formation of the
full-length GLI3 activator, which translocates to the nucleus
and activates its target genes. This is supported by the observa-
tion that all three, MID1 knockdown, Fu knockdown, and inhi-
bition of proteasomal cleavage of Fu, lead to similar effects,
which are the cytosolic retention and deactivation of GLI3.
Because our data were collected in cancer cell lines, it is plausi-
ble to believe that the “overproduction” of cleaved Fu and the
thereby induced “overactivity” ofGLI3might contribute to can-
cerogenesis and support tumor development, making the
N-term Fu isoform an interesting new cancer target.
Acknowledgments—We thank Meike Brömer and Dan Ehninger for
critical reading of the paper.
REFERENCES
1. Nybakken, K., and Perrimon, N. (2002) Hedgehog signal transduction:
recent findings. Curr. Opin. Genet. Dev. 12, 503–511
2. Ingham, P.W., andMcMahon, A. P. (2001) Hedgehog signaling in animal
development: paradigms and principles. Genes Dev. 15, 3059–3087
3. Villavicencio, E. H.,Walterhouse, D.O., and Iannaccone, P.M. (2000) The
sonic hedgehog-patched-gli pathway in human development and disease.
Am. J. Hum. Genet. 67, 1047–1054
4. Murone, M., Rosenthal, A., and de Sauvage, F. J. (1999) Hedgehog signal
transduction: from flies to vertebrates. Exp. Cell Res. 253, 25–33
5. Nybakken, K. E., Turck, C. W., Robbins, D. J., and Bishop, J. M. (2002)
Hedgehog-stimulated phosphorylation of the kinesin-related protein
Costal2 is mediated by the serine/threonine kinase fused. J. Biol. Chem.
277, 24638–24647
6. Therond, P. P., Knight, J. D., Kornberg, T. B., and Bishop, J. M. (1996)
Phosphorylation of the fused protein kinase in response to signaling from
hedgehog. Proc. Natl. Acad. Sci. U.S.A. 93, 4224–4228
7. Hammerschmidt, M., Brook, A., and McMahon, A. P. (1997) The world
according to hedgehog. Trends Genet. 13, 14–21
8. Carpenter, D., Stone, D. M., Brush, J., Ryan, A., Armanini, M., Frantz, G.,
Rosenthal, A., and de Sauvage, F. J. (1998) Characterization of two patched
receptors for the vertebrate hedgehog protein family. Proc. Natl. Acad. Sci.
U.S.A. 95, 13630–13634
9. Hui, C. C., Slusarski, D., Platt, K. A., Holmgren, R., and Joyner, A. L. (1994)
Expression of three mouse homologs of the Drosophila segment polarity
gene cubitus interruptus, Gli, Gli-2, and Gli-3, in ectoderm- and meso-
derm-derived tissues suggests multiple roles during postimplantation de-
velopment. Developmental biology 162, 402–413
10. Ruppert, J. M., Vogelstein, B., Arheden, K., and Kinzler, K.W. (1990) GLI3
encodes a 190-kilodalton protein with multiple regions of GLI similarity.
Mol. Cell Biol. 10, 5408–5415
11. Murone, M., Luoh, S. M., Stone, D., Li, W., Gurney, A., Armanini, M.,
Grey, C., Rosenthal, A., and de Sauvage, F. J. (2000) Gli regulation by the
opposing activities of fused and suppressor of fused.Nature cell biology 2,
310–312
12. Osterlund, T., Everman, D. B., Betz, R. C., Mosca, M., Nothen, M. M.,
Schwartz, C. E., Zaphiropoulos, P. G., andToftgard, R. (2004) The FUgene
and its possible protein isoforms. BMC Genomics 5, 49
13. Daoud, F., and Blanchet-Tournier, M. F. (2005) Expression of the human
FUSED protein in Drosophila. Dev. Genes Evol. 215, 230–237
14. Merchant, M., Evangelista, M., Luoh, S. M., Frantz, G. D., Chalasani, S.,
Carano, R. A., van Hoy, M., Ramirez, J., Ogasawara, A. K., McFarland,
L.M., Filvaroff, E. H., French, D.M., and de Sauvage, F. J. (2005) Loss of the
serine/threonine kinase fused results in postnatal growth defects and le-
thality due to progressive hydrocephalus.Mol. Cell Biol. 25, 7054–7068
15. Chen, M. H., Gao, N., Kawakami, T., and Chuang, P. T. (2005) Mice defi-
cient in the fused homolog do not exhibit phenotypes indicative of per-
turbed hedgehog signaling during embryonic development.Mol. Cell Biol.
25, 7042–7053
MID1 Catalyzes Ubiquitination and Cleavage of Fu
31816 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 289•NUMBER 46•NOVEMBER 14, 2014
 at M
A
X
 D
ELBRU
ECK
 CEN
TRU
M
 FU
E on N
ovem
ber 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
16. Krauss, S., Foerster, J., Schneider, R., and Schweiger, S. (2008) Protein
phosphatase 2A and rapamycin regulate the nuclear localization and ac-
tivity of the transcription factor GLI3. Cancer Res. 68, 4658–4665
17. Krauss, S., So, J., Hambrock, M., Kohler, A., Kunath, M., Scharff, C.,
Wessling, M., Grzeschik, K. H., Schneider, R., and Schweiger, S. (2009)
Point mutations in GLI3 lead to misregulation of its subcellular localiza-
tion. PLoS ONE 4, e7471
18. Trockenbacher, A., Suckow, V., Foerster, J., Winter, J., Krauss, S., Ropers,
H. H., Schneider, R., and Schweiger, S. (2001) MID1, mutated in Opitz
syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for
degradation. Nat. Genet. 29, 287–294
19. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Prob-
ability-based protein identification by searching sequence databases using
mass spectrometry data. Electrophoresis 20, 3551–3567
20. Dierks, C., Grbic, J., Zirlik, K., Beigi, R., Englund,N. P., Guo,G. R., Veelken,
H., Engelhardt, M., Mertelsmann, R., Kelleher, J. F., Schultz, P., and War-
muth, M. (2007) Essential role of stromally induced hedgehog signaling in
B-cell malignancies. Nature medicine 13, 944–951
21. Kise, Y., Takenaka, K., Tezuka, T., Yamamoto, T., and Miki, H. (2006)
Fused kinase is stabilized by Cdc37/Hsp90 and enhances Gli protein lev-
els. Biochem. Biophys. Res. Commun. 351, 78–84
22. Li,W., Tu, D., Brunger, A. T., and Ye, Y. (2007) A ubiquitin ligase transfers
preformed polyubiquitin chains from a conjugating enzyme to a substrate.
Nature 446, 333–337
23. Ravid, T., andHochstrasser,M. (2007) Autoregulation of an E2 enzyme by
ubiquitin-chain assembly on its catalytic residue. Nature cell biology 9,
422–427
24. Meroni, G., andDiez-Roux, G. (2005) TRIM/RBCC, a novel class of ’single
protein RING finger’ E3 ubiquitin ligases. BioEssays: news and reviews in
molecular, cellular and developmental biology 27, 1147–1157
25. Li, W., and Ye, Y. (2008) Polyubiquitin chains: functions, structures, and
mechanisms. Cellular and molecular life sciences: CMLS 65, 2397–2406
26. Pickart, C. M., and Fushman, D. (2004) Polyubiquitin chains: polymeric
protein signals. Current opinion in chemical biology 8, 610–616
27. Kravtsova-Ivantsiv, Y., Sommer, T., and Ciechanover, A. (2013) The ly-
sine48-based polyubiquitin chain proteasomal signal: not a single child
anymore. Angewandte Chemie 52, 192–198
28. Xu, P., Duong, D.M., Seyfried, N. T., Cheng, D., Xie, Y., Robert, J., Rush, J.,
Hochstrasser, M., Finley, D., and Peng, J. (2009) Quantitative proteomics
reveals the function of unconventional ubiquitin chains in proteasomal
degradation. Cell 137, 133–145
29. Kirkpatrick, D. S., Hathaway, N. A., Hanna, J., Elsasser, S., Rush, J., Finley,
D., King, R. W., and Gygi, S. P. (2006) Quantitative analysis of in vitro
ubiquitinated cyclin B1 reveals complex chain topology. Nature cell biol-
ogy 8, 700–710
30. Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K. Y., Zaitseva, T. S.,
Becker, C. H., Bates, G. P., Schulman, H., and Kopito, R. R. (2007) Global
changes to the ubiquitin system in Huntington’s disease. Nature 448,
704–708
31. Meierhofer, D., Wang, X., Huang, L., and Kaiser, P. (2008) Quantitative
analysis of global ubiquitination in HeLa cells bymass spectrometry. Jour-
nal of proteome research 7, 4566–4576
32. Jacob, J., and Briscoe, J. (2003) Gli proteins and the control of spinal-cord
patterning. EMBO Rep. 4, 761–765
33. Maloveryan, A., Finta, C., Osterlund, T., and Kogerman, P. (2007) A pos-
sible role of mouse Fused (STK36) in Hedgehog signaling and Gli tran-
scription factor regulation. Journal of cell communication and signaling 1,
165–173
34. Berman, D. M., Karhadkar, S. S., Maitra, A., Montes De Oca, R., Gersten-
blith,M. R., Briggs, K., Parker, A. R., Shimada, Y., Eshleman, J. R.,Watkins,
D. N., and Beachy, P. A. (2003) Widespread requirement for Hedgehog
ligand stimulation in growth of digestive tract tumours. Nature 425,
846–851
35. Watkins, D. N., Berman, D.M., Burkholder, S. G.,Wang, B., Beachy, P. A.,
and Baylin, S. B. (2003) Hedgehog signalling within airway epithelial pro-
genitors and in small-cell lung cancer. Nature 422, 313–317
36. Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts,
D. J., Lauwers, G. Y., Qi, Y. P., Gysin, S., Fernandez-del Castillo, C., Yajnik,
V., Antoniu, B., McMahon, M., Warshaw, A. L., and Hebrok, M. (2003)
Hedgehog is an early and late mediator of pancreatic cancer tumorigene-
sis. Nature 425, 851–856
37. Sanchez, P., Hernandez, A. M., Stecca, B., Kahler, A. J., DeGueme, A. M.,
Barrett, A., Beyna, M., Datta, M. W., Datta, S., and Ruiz i Altaba, A.
(2004) Inhibition of prostate cancer proliferation by interference with
SONIC HEDGEHOG-GLI1 signaling. Proc. Natl. Acad. Sci. U.S.A. 101,
12561–12566
38. Han, X., Du,H., andMassiah,M.A. (2011)Detection and characterization
of the in vitro e3 ligase activity of the human MID1 protein. Journal of
molecular biology 407, 505–520
39. Napolitano, L. M., Jaffray, E. G., Hay, R. T., and Meroni, G. (2011) Func-
tional interactions between ubiquitin E2 enzymes andTRIMproteins.The
Biochemical journal 434, 309–319
40. Kim, Y. S., Kang, H. S., and Jetten, A. M. (2007) The Kruppel-like zinc
finger protein Glis2 functions as a negative modulator of the Wnt/beta-
catenin signaling pathway. FEBS Lett. 581, 858–864
MID1 Catalyzes Ubiquitination and Cleavage of Fu
NOVEMBER 14, 2014•VOLUME 289•NUMBER 46 JOURNAL OF BIOLOGICAL CHEMISTRY 31817
 at M
A
X
 D
ELBRU
ECK
 CEN
TRU
M
 FU
E on N
ovem
ber 17, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
